


Nabriva Therapeutics plc
Biotechnology Research • Dublin, Co Dublin, Ireland • 21-50 Employees
Company overview
| Headquarters | 25-28 North Wall Quay, Dublin, - -, IE |
| Phone number | +35316492000 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2006 |
| Employees | 21-50 |
| Socials |
Key Contacts at Nabriva Therapeutics plc
Diane Cain
Director, National Accounts, Market Access
Bruno Fontanot
Senior Director, Financial Reporting & Compliance, Treasurer - U.S.
Dempsey Wang
Regional Sales Director
Patrick Scoble
Senior Director Medical Affairs
Fred Andrush
Director, Customer Insights And Commerciasl Forecasting
Eric Parker
Associate Director Of Alliance Management
Colin Broome
Executive Assistant To Chief Executive Officer
Nabriva Therapeutics plc Email Formats
Nabriva Therapeutics plc uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@nabriva.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@nabriva.com | 100% |
About Nabriva Therapeutics plc
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta (lefamulin), recently approved by the FDA for both Oral and IV use and CONTEPO (fosfomycin) for injection, we submitted an NDA for CONTEPO, a potential first-in-class epoxide antibiotic in the United States for complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP). Our corporate headquarters are in Dublin, Ireland with offices and labs located in Vienna, Austria and King of Prussia, PA. Nabriva is a commercial-stage biopharmaceutical company with locations in the United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.
Nabriva Therapeutics plc revenue & valuation
| Annual revenue | $29,600,000 |
| Revenue per employee | $1,095,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $94,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Nabriva Therapeutics plc has 11 employees across 7 departments.
Departments
Number of employees
Funding Data
Nabriva Therapeutics plc has never raised funding before.
Nabriva Therapeutics plc Tech Stack
Discover the technologies and tools that power Nabriva Therapeutics plc's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
CDN
CMS
Accessibility
JavaScript libraries
PaaS
Tag managers
Webmail
Miscellaneous
Font scripts
UI frameworks
Frequently asked questions
4.8
40,000 users



